| Mon, 14 Oct 2019 15:40:03: | J&J, Bayer's Xarelto scores FDA nod to treat acutely ill patients during and after hospitalization
|
| Mon, 14 Oct 2019 15:31:15: | AZ got past FluMist's efficacy woes, but now it's plagued by production problems
|
| Mon, 14 Oct 2019 13:52:16: | Purdue, billionaire founders win temporary reprieve from lawsuits in hopes of reaching deal
|
| Mon, 14 Oct 2019 13:12:51: | FiercePharmaPolitics—PhRMA attacks Pelosi plan as CBO says it would lower spending; drugmakers raise more prices
|
| Sat, 12 Oct 2019 12:57:07: | Can J&J, on the litigation hot seat, hold off long-term brand and reputation damage?
|
| Fri, 11 Oct 2019 20:08:43: | Eli Lilly's Reyvow wins FDA nod for migraine relief, but side effects could limit sales: analyst
|
| Fri, 11 Oct 2019 14:50:42: | ICER says AbbVie's Rinvoq for RA may be cost-effective but still questions the value of JAK class
|
| Fri, 11 Oct 2019 14:43:09: | J&J, besieged by lawsuits, could be a steal for investors: analyst
|
| Fri, 11 Oct 2019 14:13:20: | Clovis' Rubraca, trailing PARP rivals, nabs England coverage thanks to NICE U-turn
|
| Fri, 11 Oct 2019 13:55:59: | Sanofi opens new $47M headquarters in U.K. with plans to employ 500
|
| Fri, 11 Oct 2019 09:33:45: | FiercePharmaAsia—Aurobindo, Glenmark FDA dings; Takeda-Prometheus IBD pact; Ascletis' new CSO
|
| Thu, 10 Oct 2019 19:03:05: | Merck CEO: When it comes to drug pricing and politics, pharma's in the 'crosshairs'
|
| Thu, 10 Oct 2019 14:00:35: | Novartis has its blockbuster Beovu OK, but its 'hot mess' label leaves something to be desired: analysts
|
| Thu, 10 Oct 2019 13:31:25: | J&J emerges unscathed in retried California talcum powder suit
|
| Wed, 09 Oct 2019 16:22:32: | BeiGene opens phase one of $320M plant with 180 workers
|
| Wed, 09 Oct 2019 15:09:42: | Amid next-gen vaccine race, Merck says ex-employee bolted to Pfizer with 'thousands' of key documents
|
| Wed, 09 Oct 2019 14:51:33: | Progenics inked a merger to avoid negotiating a proxy war. One activist still wants to fight
|
| Wed, 09 Oct 2019 14:21:19: | GSK joins other drugmakers recalling Zantac products
|
| Wed, 09 Oct 2019 13:20:47: | Clinuvel scores long-awaited FDA win for rare skin disease implant Scenesse
|
| Wed, 09 Oct 2019 13:16:32: | Jury smacks J&J with $8B Risperdal verdict, but will it stand up in appeals?
|
| Tue, 08 Oct 2019 14:49:36: | California bans pharma's infamous 'pay-for-delay' deals
|
| Tue, 08 Oct 2019 13:46:46: | AbbVie's Humira, Roche's Rituxan top ICER's list of worst price-hike offenders
|
| Tue, 08 Oct 2019 13:36:21: | AMAG bails on proxy fight standoff with settlement for 2 board seats
|
| Tue, 08 Oct 2019 12:57:58: | Aurobindo chalks up new FDA manufacturing concerns
|
| Tue, 08 Oct 2019 12:54:48: | Novartis takes on Regeneron, Roche blockbusters with Beovu approval
|
